VACCINATION WITH AUTOLOGOUS DENDRITIC CELLS LOADED WITH AUTOLOGOUS TUMOR LYSATE OR HOMOGENATE COMBINED WITH IMMUNOMODULATING RADIOTHERAPY AND/OR PRELEUKAPHERESIS IFN-ALFA IN PATIENTS WITH METASTATIC MELANOMA: A RANDOMIZED "PROOF-OF-PRINCIPLE" PHASE II STUDY: